Next Article in Journal / Special Issue
Is Five Percent Too Small? Analysis of the Overlaps between Disorder, Coiled Coil and Collagen Predictions in Complete Proteomes
Previous Article in Journal / Special Issue
Respiratory Proteomics Today: Are Technological Advances for the Identification of Biomarker Signatures Catching up with Their Promise? A Critical Review of the Literature in the Decade 2004–2013
Open AccessReview

Proteomic Applications in the Study of Human Mesenchymal Stem Cells

1
Rheumatology Division, ProteoRed/ISCIII, INIBIC-Hospital Universitario A Coruña, A Coruña 15006, Spain
2
CIBER-BBN, INIBIC-Hospital Universitario A Coruña, A Coruña 15006, Spain
3
Department of Medicine, University of A Coruña, A Coruña 15006, Spain
4
Department of Medicine, University of Santiago de Compostela, Santiago de Compostela 15782, Spain
*
Author to whom correspondence should be addressed.
Proteomes 2014, 2(1), 53-71; https://doi.org/10.3390/proteomes2010053
Received: 4 December 2013 / Revised: 15 January 2014 / Accepted: 26 January 2014 / Published: 7 February 2014
(This article belongs to the Special Issue Feature Paper 2013)
Mesenchymal stem cells (MSCs) are undifferentiated cells with an unlimited capacity for self-renewal and able to differentiate towards specific lineages under appropriate conditions. MSCs are, a priori, a good target for cell therapy and clinical trials as an alternative to embryonic stem cells, avoiding ethical problems and the chance for malignant transformation in the host. However, regarding MSCs, several biological implications must be solved before their application in cell therapy, such as safe ex vivo expansion and manipulation to obtain an extensive cell quantity amplification number for use in the host without risk accumulation of genetic and epigenetic abnormalities. Cell surface markers for direct characterization of MSCs remain unknown, and the precise molecular mechanisms whereby growth factors stimulate their differentiation are still missing. In the last decade, quantitative proteomics has emerged as a promising set of techniques to address these questions, the answers to which will determine whether MSCs retain their potential for use in cell therapy. Proteomics provides tools to globally analyze cellular activity at the protein level. This proteomic profiling allows the elucidation of connections between broad cellular pathways and molecules that were previously impossible to determine using only traditional biochemical analysis. However; thus far, the results obtained must be orthogonally validated with other approaches. This review will focus on how these techniques have been applied in the evaluation of MSCs for their future applications in safe therapies. View Full-Text
Keywords: mesenchymal stem cell; proteomic analysis; characterization; differentiation mesenchymal stem cell; proteomic analysis; characterization; differentiation
Show Figures

Figure 1

MDPI and ACS Style

Mateos, J.; Pernas, P.F.; Labora, J.F.; Blanco, F.; Arufe, M.D.C. Proteomic Applications in the Study of Human Mesenchymal Stem Cells. Proteomes 2014, 2, 53-71.

Show more citation formats Show less citations formats

Article Access Map

1
Only visits after 24 November 2015 are recorded.
Back to TopTop